Health

Supported by EIT Health

CalibraMics

Reliable and consistent medical imaging data

CalibraMics solves the problem of inconsistent and unreliable data from medical CT scanners. This ensures that AI models and clinical trials produce trustworthy results.

  • Detects and fixes data drift across different scanners and hospitals.
  • Validates imaging biomarkers to ensure accurate, repeatable measurements.
  • Helps AI models and clinical trials maintain performance and reliability.
  • Speeds up regulatory approval for new drugs and AI-based tools.

Türkiye

LinkedIn

Founders

Alper Selver

Co-founder

CheMOnitor

Blood test for chemo effectiveness

CheMonitor solves the problem of not knowing if a patient’s lung cancer chemotherapy is working. Our blood test allows doctors to monitor treatment response quickly and adjust it for better results.

  • Uses a unique blood test combining glycomics and AI for analysis.
  • Monitors patient-specific response to lung cancer chemotherapy.
  • Fits easily into daily clinical workflow for regular check-ups.
  • Provides essential, previously unavailable data to help guide treatment.

Hungary

Founders

Rebeka Török

Co-founder

MYLeukaemia

Test leukemia drugs on patient's cells

MYLeukaemia solves the problem of choosing an ineffective chemotherapy for blood cancer patients. Our test finds the most effective approved drug for each individual before treatment begins.

  • Tests drugs on a patient’s own cancer cells using a bone-marrow-on-a-chip.
  • Delivers a ranked therapy report to doctors in about 72 hours.
  • Reduces exposure to ineffective chemo and speeds up time to remission.
  • Led by an experienced team and preparing for hospital pilot studies.

Portugal (Madeira)

LinkedIn

Founders

Hugo R. Caires

Co-founder

Hugo Prazeres

Co-founder

Oncosort

Automating cancer drug reimbursement checks

Oncosort solves the slow and complex process for getting cancer drug treatments approved for reimbursement. The platform automates the paperwork so hospitals can qualify patients faster.

  • Automates patient eligibility checks using AI and hospital data.
  • Cuts administrative work for hospital staff, freeing up their time.
  • Speeds up patient access to new and innovative cancer drugs.
  • Ensures compliance with complex drug reimbursement programme rules.

Poland

LinkedIn

Founders

Mateusz Lickindorf

Founder & CEO

Damian Grzywacz

Co-founder & COO

Prospect Biotech

AI-powered sensors for cell therapy

Prospect Biotech solves the challenge of monitoring live cell cultures during advanced therapy manufacturing. The company’s optical sensors provide real-time analysis to optimise production.

  • Uses Raman and SERS spectroscopy for non-invasive, real-time monitoring of cell cultures.
  • Applies AI to analyse biochemical changes and enable predictive process control.
  • Offers a B2B model with hardware and data services for biotech and pharma.
  • Currently validating prototypes at TRL 5-6 in real production environments.

Spain

Founders

Javier Plou

Founder

VentiPET

First gaseous PET tracer for lungs

VentiPET solves the need for a precise and safe way to image lung function. Its technology is the first gaseous radiotracer for PET scans, revolutionizing how respiratory diseases are diagnosed.

  • Uses the first-ever gaseous PET tracer, [¹⁸F]SF₆, for high-precision lung imaging.
  • Enables faster and safer diagnosis of respiratory diseases compared to current methods.
  • Provides a complete, ready-to-use system with a safe, disposable delivery device.
  • Offers hospitals a revolutionary tool for visualising and quantifying lung ventilation.

Spain

LinkedIn

Founders

See the Other Finalists

Food & Agritech

Energy & Renewables

New European Bauhaus

Raw Materials

Rebuild Ukraine

Smart Cities and Mobility